| P50 | author | Giuseppe Pignataro | Q56940551 |
| | Angelo Serani | Q86970238 |
| P2093 | author name string | Paola Brancaccio | |
| | Lucio Annunziato | |
| | Giusy Laudati | |
| | Natascia Guida | |
| | Ornella Cuomo | |
| | Serenella Anzilotti | |
| | Valeria Valsecchi | |
| P2860 | cites work | Purification of native survival of motor neurons complexes and identification of Gemin6 as a novel component | Q24292040 |
| | Identification and characterization of Gemin7, a novel component of the survival of motor neuron complex | Q24299793 |
| | The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins | Q24316085 |
| | MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions | Q28080201 |
| | Characterization of a nuclear 20S complex containing the survival of motor neurons (SMN) protein and a specific subset of spliceosomal Sm proteins | Q28143590 |
| | Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy | Q28289793 |
| | The K+/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation | Q28296169 |
| | Identification and characterization of a spinal muscular atrophy-determining gene | Q29547495 |
| | A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy | Q29617367 |
| | miRNA malfunction causes spinal motor neuron disease | Q30495998 |
| | Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? | Q33785933 |
| | A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. | Q33864982 |
| | Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes | Q34127486 |
| | Aβ1-42 monomers or oligomers have different effects on autophagy and apoptosis | Q34344718 |
| | Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy | Q34353103 |
| | Essential role for the SMN complex in the specificity of snRNP assembly | Q34529450 |
| | Selective vulnerability of spinal and cortical motor neuron subpopulations in delta7 SMA mice | Q35064279 |
| | MiR-206, a key modulator of skeletal muscle development and disease. | Q35069217 |
| | Expression of Muscle-Specific MiRNA 206 in the Progression of Disease in a Murine SMA Model | Q35647837 |
| | MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review | Q36037933 |
| | Genetic ablation of homeodomain-interacting protein kinase 2 selectively induces apoptosis of cerebellar Purkinje cells during adulthood and generates an ataxic-like phenotype. | Q36485117 |
| | ncx1, ncx2, and ncx3 gene product expression and function in neuronal anoxia and brain ischemia. | Q36796672 |
| | MicroRNA-206: the skeletal muscle-specific myomiR. | Q37125050 |
| | Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy | Q37238936 |
| | MicroRNA-206: a promising theranostic marker. | Q37511094 |
| | Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production | Q37614887 |
| | Transcriptional regulation of ncx1 gene in the brain | Q38066045 |
| | Sodium-calcium exchangers (NCX): molecular hallmarks underlying the tissue-specific and systemic functions. | Q38166672 |
| | Does Na⁺/Ca²⁺ exchanger, NCX, represent a new druggable target in stroke intervention? | Q38170046 |
| | The role of miRNA in motor neuron disease. | Q38187648 |
| | Muscle-specific microRNAs in skeletal muscle development. | Q38680579 |
| | MotomiRs: miRNAs in Motor Neuron Function and Disease | Q39316843 |
| | NCX1 is a novel target gene for hypoxia-inducible factor-1 in ischemic brain preconditioning. | Q39598040 |
| | Defective Ca2+ channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy | Q39751507 |
| | Correlation between severity and SMN protein level in spinal muscular atrophy | Q41102726 |
| | RETRACTED ARTICLE: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN | Q41275236 |
| | Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy. | Q42168364 |
| | p38/Sp1/Sp4/HDAC4/BDNF Axis Is a Novel Molecular Pathway of the Neurotoxic Effect of the Methylmercury | Q42329902 |
| | MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice | Q42722532 |
| | NCX1 is a new rest target gene: role in cerebral ischemia | Q43441343 |
| | nNOS and p-ERK involvement in the neuroprotection exerted by remote postconditioning in rats subjected to transient middle cerebral artery occlusion | Q44295654 |
| | Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy | Q46272554 |
| | Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitis | Q46466635 |
| | Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy. | Q46613106 |
| | Overexpression of miR-206 ameliorates chronic constriction injury-induced neuropathic pain in rats via the MEK/ERK pathway by targeting brain-derived neurotrophic factor | Q47337090 |
| | Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice. | Q47807997 |
| | Sp3/REST/HDAC1/HDAC2 Complex Represses and Sp1/HIF-1/p300 Complex Activates ncx1 Gene Transcription, in Brain Ischemia and in Ischemic Brain Preconditioning, by Epigenetic Mechanism. | Q48179085 |
| | miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model | Q48397272 |
| | A new concept: Aβ1-42 generates a hyperfunctional proteolytic NCX3 fragment that delays caspase-12 activation and neuronal death. | Q48421059 |
| | Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET/CT. | Q48946777 |
| | Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy. | Q49304342 |
| | Advances in spinal muscular atrophy therapeutics | Q49874005 |
| | Preconditioning, induced by sub-toxic dose of the neurotoxin L-BMAA, delays ALS progression in mice and prevents Na+/Ca2+ exchanger 3 downregulation. | Q50046171 |
| | Survival of motor neuron protein downregulates miR-9 expression in patients with spinal muscular atrophy. | Q50457381 |
| | The miR206-JunD circuit mediates the neurotoxic effect of methylmercury in cortical neurons. | Q51742244 |
| | Inhibition of autophagy delays motoneuron degeneration and extends lifespan in a mouse model of spinal muscular atrophy. | Q52739291 |
| | Ionic Homeostasis Maintenance in ALS: Focus on New Therapeutic Targets | Q57170405 |
| | Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis | Q57661623 |
| | Pharmacological c-Jun NH-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease in Mice | Q58764859 |
| | SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN | Q81385781 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P577 | publication date | 2020-01-15 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | miR-206 Reduces the Severity of Motor Neuron Degeneration in the Facial Nuclei of the Brainstem in a Mouse Model of SMA | |